Patents by Inventor Erica McKenzie Bell

Erica McKenzie Bell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10480033
    Abstract: The lack of clear predictors of prostate cancer progression leads to subjective decision-making regarding courses of treatment. The identification of new biomarkers that are predictive of recurrence after radical prostatectomy would advance the field of prostate cancer treatment. Disclosed are miRNAs that can be used as molecular biomarkers to detect or predict the progression of prostate cancer and to adjust a treatment plan accordingly. Furthermore, kits are included for the detection of these miRNAs.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: November 19, 2019
    Assignees: Ohio State Innovation Foundation, University of Freiburg
    Inventors: Arnab Chakravarti, Erica McKenzie Bell, Simon Kirste, Anca-Ligia Grosu
  • Publication number: 20180002762
    Abstract: The lack of clear predictors of prostate cancer progression leads to subjective decision-making regarding courses of treatment. The identification of new biomarkers that are predictive of recurrence after radical prostatectomy would advance the field of prostate cancer treatment. Disclosed are miRNAs that can be used as molecular biomarkers to detect or predict the progression of prostate cancer and to adjust a treatment plan accordingly. Furthermore, kits are included for the detection of these miRNAs.
    Type: Application
    Filed: January 14, 2016
    Publication date: January 4, 2018
    Inventors: Arnab Chakravarti, Erica McKenzie Bell, Simon Kirste, Anca-Ligia Grosu